MichaelHSilvermanMDFACP

Rheumatology • Marblehead, MA

President and Senior Clinical Development Consultant, BioStrategics Consulting Ltd

Join to view full profile

Dr. Silverman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Silverman's full profile

Already have an account?

Office
51 Intrepid Circle
Biostrategics Consulting Ltd
Marblehead, MA 01945
Phone+1 781-631-8596

Education & Training

University of ColoradoFellowship, Rheumatology, 1976 - 1978
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1973 - 1976
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1973

Certifications & Licensure

MA State Medical License 1993 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Clinical Trials

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients Start of enrollment: 2006 Jun 01
Completed
Phase 2
A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail Start of enrollment: 2006 Sep 01
Completed
Phase 2
Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients Start of enrollment: 2008 Feb 01
Completed
Phase 2
A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma Start of enrollment: 2009 Feb 01
Completed
Phase 1, Phase 2
A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1 Start of enrollment: 2009 Jul 01
Completed
Phase 1, Phase 2
A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee Start of enrollment: 2018 Nov 01
Withdrawn
Phase 2
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure Start of enrollment: 2010 Oct 01
Completed
Phase 2
Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis Start of enrollment: 2010 Oct 01
Completed
Phase 2
Trial of CF101 to Treat Patients With Dry Eye Disease Start of enrollment: 2011 Jul 01
Completed
Phase 3
Trial of CF101 to Treat Patients With Psoriasis Start of enrollment: 2011 Jul 01
Completed
Phase 2, Phase 3
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers Start of enrollment: 2014 Jun 01
Completed
Phase 3
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers Start of enrollment: 2014 Jun 01
Completed
Phase 3
Join now to see all

Professional Memberships

American College of Physicians - ACP
Fellow